Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial
Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page
- Check2 days agoChange DetectedThe record history now reflects a newer revision tag (v3.6.2) replacing the older v3.6.0, signaling a minor backend update to the page rather than a change to trial data. No substantive trial information is modified.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe history adds a note that the study is no longer recruiting participants and updates the record revision to v3.6.0, replacing the prior v3.5.5 label.SummaryDifference0.2%

- Check23 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, indicating an update to the page metadata. This reflects an administrative update to the record rather than changes to the study details.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history now shows a new revision tag v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's revision history metadata.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s UI/version footer was updated from revision v3.5.2 to v3.5.3. This reflects a technical site update rather than any change to the underlying clinical trial record.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the history.SummaryDifference0.1%

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.